Screening, library‐assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization

Journal of Mass Spectrometry - Tập 38 Số 3 - Trang 283-295 - 2003
Carsten Kratzsch1, Frank T. Peters1, Thomas Kræmer1, Achim Weber1, Hans H. Maurer1
1Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Saarland, D-66421 Homburg (Saar), Germany

Tóm tắt

AbstractA liquid chromatographic/mass spectrometric assay with atmospheric pressure chemical ionization (APCI‐LC/MS) is presented for the fast and reliable screening and identification and for the precise and sensitive quantification of 15 neuroleptic (antipsychotic) drugs and three of their relevant metabolites in plasma. It allows confirmation of the diagnosis of a neuroleptic overdose and monitoring of psychiatric patients' compliance. The neuroleptics amisulpride, bromperidol, clozapine, droperidol, flupenthixol, fluphenazine, haloperidol, melperone, olanzapine, perazine, pimozide, risperidone, sulpiride, zotepine and zuclopenthixol and the pharmacologically active metabolites norclozapine, clozapine N‐oxide and 9‐hydroxyrisperidone were extracted from plasma using solid‐phase extraction and were separated on a Merck LiChroCART column with Superspher 60 RP Select B as the stationary phase. Gradient elution was performed using aqueous ammonium formate and acetonitrile. After screening and identification in the scan mode using the authors' new LC/MS library, the neuroleptics were quantified in the selected‐ion mode. The quantification assay was fully validated. It was found to be selective and proved to be linear from sub‐therapeutic to over therapeutic concentrations for all analytes. The corresponding reference levels are listed. The accuracy and precision data were within the required limits. The analytes were stable in frozen plasma for at least 1 month. The method was successfully applied to several authentic plasma samples from patients treated or intoxicated with various neuroleptics. The validated LC/MS assay has proved to be appropriate for the isolation, separation, screening, identification and quantification of various neuroleptics in plasma for clinical toxicology and therapeutic drug monitoring purposes. Copyright © 2003 John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

Kratzsch C, 2002, Proceedings of the 40th International Meeting of The International Association of Forensic Toxicologists (TIAFT), Paris

Maurer H, 1983, J. Chromatogr., 272, 75, 10.1016/S0378-4347(00)86104-6

10.1016/S0378-4347(00)80876-2

10.2174/1386207003331355

10.1002/jps.2600820503

10.1016/0378-4347(93)80327-Z

10.1159/000028347

10.1016/S0378-4347(00)00323-6

10.1016/S0731-7085(98)00261-1

10.1016/S0378-4347(97)00302-2

10.1002/1096-9888(200006)35:6<718::AID-JMS999>3.0.CO;2-O

Kratzsch C, 2001, Proceedings of the XIIth GTFCh Symposium, Mosbach, 76

10.1097/00007691-200202000-00019

10.1520/JFS14697J

10.1097/00007691-199706000-00011

10.1016/S0378-4347(00)00438-2

10.1016/S0378-4347(98)00205-9

10.1097/00007691-199902000-00013

10.1002/(SICI)1096-9888(1998100)33:10<1003::AID-JMS716>3.0.CO;2-P

10.1016/S0378-4347(99)00287-X

10.1016/S0378-4347(00)00461-8

10.1016/0378-4347(95)00420-3

Moulin A, 1991, Eur. J. Drug Metab Pharmacokinet., 3, 507

10.1016/S0378-4347(96)00428-8

10.1016/S0378-4347(00)84052-9

10.1093/jat/19.7.537

10.1016/S0378-4347(99)00230-3

10.1016/S0378-4347(98)00202-3

Chang WH, 1997, J. Formos. Med. Assoc., 96, 599

10.1097/00007691-199604000-00015

Volpicelli SA, 1993, Clin. Chem., 39, 1656, 10.1093/clinchem/39.8.1656

10.1016/S0731-7085(01)00410-1

Pan L, 1998, Ther. Drug Monit., 20, 224, 10.1097/00007691-199804000-00015

Kumar K, 1996, J. Pharm. Biomed. Anal., 14, 1529, 10.1016/0731-7085(96)01797-9

Haring N, 1987, Arzneim.‐Forsch., 37, 1402

Chan KY, 1983, J. Chromatogr., 274, 121, 10.1016/S0378-4347(00)84415-1

10.1016/S0378-4347(96)00294-0

10.1016/S0731-7085(99)00107-7

10.1097/00007691-200104000-00011

10.1016/S0378-4347(98)00432-0

10.1016/0378-4347(94)00245-2

Kerbusch T, 1997, J. Chromatogr. B, 694, 163, 10.1016/S0378-4347(97)00152-7

Miyao Y, 1983, J. Chromatogr., 275, 443, 10.1016/S0378-4347(00)84394-7

10.1097/00007691-198506000-00016

10.1002/bms.1200101004

10.1111/j.1365-2710.1995.tb00629.x

10.1002/1096-9888(200009)35:9<1091::AID-JMS31>3.0.CO;2-M

Peters FT, 2002, Clin. Chem., 48, 1472, 10.1093/clinchem/48.9.1472

Maurer HH, 2003, APCI and Electrospray LC–MS Library of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites

NCCLS Evaluation of Precision Performance of Clinical Chemistry Devices; Approved Guideline. NCCLS Document EP5‐A. NCCLS: Wayne PA 1999.

Maurer HH, 2000, Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites, Part 4, 3

10.1002/jms.325

10.1016/S1570-0232(01)00618-3

10.1016/S0378-4347(00)00270-X

10.1002/jms.201

10.1016/S0378-4347(01)00249-3

10.1023/A:1015829422034

10.1023/A:1007669411738

10.1016/S0378-4347(98)00027-9

10.1007/s00769-002-0516-5

BPI Fachinfo CD Version2002; Editio Cantor Verlag: Aulendorf 2002.

10.1016/S0379-0738(01)00483-2

Baselt RC, 2002, Disposition of Toxic Drugs and Chemicals in Man

Bircher J, 1999, Klinisch‐pharmakologische Datensammlung

Schulz M, 1997, Pharmazie, 52, 895

Meyer FP, 1994, Int. J. Clin. Pharmacol. Ther., 32, 71